Abstract Submission
Program Committee
CME Activity

The George Washington University NCI

The National Institutes of Health and The George Washington University Medical Center present

12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
Lister Hill Auditorium, NIH Main Campus, Bethesda, Maryland
April 26-27, 2010

***As a registered attendee of the 12th ICMAOI meeting, we want to make you aware of the Continuing Medical Educational activity being offered through this meeting.

Description: The International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies is the only forum that is solely focused on presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected and other immunosuppressed individuals. This conference will address basic and clinical research on viral oncology, immunology, genetics, epidemiology, pathogenesis, drug discovery, early diagnosis, and clinical investigation of malignant diseases in AIDS and other immunodeficiency states including organ transplantation.

This activity is intended for practicing clinical oncologists, pathologists, hematologists, infectious disease specialists and others involved, interested, or participating in malignancy research in HIV/AIDS and other immunodeficiencies and in tumor virology.

Objectives: After attending this activity, the participant should be able to:

  • Propose trends of specific malignancies that may occur in the context of HIV infection (AIDS defining and non-AIDS defining) and other acquired immunodeficiencies, and identify cofactors (ie. environmental, viral, and behavioral) that may be associated with the development of these malignancies, if known. Describe which populations (geographic, ethnic, racial, sex, age, etc.) may be predisposed to developing specific malignancies.
  • Describe how the use of state-of-the-science information in the epidemiology, pathogenesis, and clinical aspects of malignancies in HIV positive and other immunocompromised patients can lead to more effective prevention, diagnosis and treatment in those that are susceptible to these malignancies.
  • Describe how chronic immunosuppression (either in transplant recipients or HIV positive individuals on HAART) impacts the incidence and types of cancer, and the choice of therapies in those patients who develop malignancies.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The George Washington University Medical Center and the National Institutes of Health.  The George Washington University Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The George Washington University Medical Center designates this educational activity for a maximum of 5 AMA PRA Category 1 CreditsTM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Speaker and Provider Disclosure:
The George Washington University Medical Center has a disclosure policy whereby everyone in a position to control the content of an educational activity must disclose all relevant financial relationships with commercial interests. In addition, speakers must also disclose any unlabled/unapproved uses of drugs or devices that they plan to discuss in their presentation(s). Individuals who fail to disclose potential conflicts of interest are disqualified from participation in planning or implementing this CME activity. Potential conflicts of interest are resolved and documented. Detailed disclosure will be made in the activity handout materials.